![](/img/cover-not-exists.png)
Longâterm safety and sustained efficacy for up to 5Â years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the BâYOND extension study
Pasi, K. John, Fischer, Kathelijn, Ragni, Margaret, Kulkarni, Roshni, Ozelo, Margareth C., Mahlangu, Johnny, Shapiro, Amy, PâNg, Stephanie, Chambost, Hervé, Nolan, Beatrice, Bennett, Carolyn, MatsuJournal:
Haemophilia
DOI:
10.1111/hae.14036
Date:
June, 2020
File:
PDF, 564 KB
2020